Christine Bentley is Managing Director, Chemistry, Manufacturing and Controls (CMC) for Cardinal Health Regulatory Sciences.
Bentley is responsible for scientific and regulatory consulting activities associated with pharmaceutical product development, as well as global regulatory affairs. Her responsibilities include managing multidisciplinary drug development teams, directing the preparation of investigational and marketing applications, directing the preparation of post-approval regulatory submissions and providing strategies for authoring documents for global registrations.
Bentley has more than 27 years of experience in the pharmaceutical industry, focusing in research and development (R&D), technical transfer, scale-up and pipeline strategies for pharmaceutical products in a variety of dosage forms. She also has experience with developing regulatory strategies (US and ex-US), compliance, intellectual property review with due diligence, milestone timelines and associated budgets, contract manufacturing and formulation development for diverse drug product offerings.
Prior to joining the Regulatory Sciences group in 2008, Bentley held a position at Cardinal Health as Director of Project Management. Prior to Cardinal Health, Bentley worked at Perrigo Company, where she held positions in R&D, technical operations and quality assurance. Her other previous roles included serving as a senior scientist at Teva, formulation manager at TCPI and formulation scientist at Hercon. Her pharmaceutical career began at Theratech, Inc.
Bentley received a bachelor’s of science degree in psychology from the University of Utah.